We are live on ! Find out more
AFA

Abacus FCF Advisors Portfolio holdings

AUM $444M
1-Year Est. Return 44.44%
This Fund
S&P 500
This Quarter Est. Return
+28.61%
1 Year Est. Return
+44.44%
3 Year Est. Return
+142.32%
5 Year Est. Return
+208.76%
10 Year Est. Return
AUM
$105M
AUM Growth
+$17.8M
Cap. Flow
-$3.36M
Cap. Flow %
-3.19%
Top 10 Hldgs %
21.74%
Holding
93
New
16
Increased
6
Reduced
59
Closed
12

Sector Composition

Rank Sector Weight
1 Technology 24.9%
2 Financials 16.6%
3 Healthcare 15.68%
4 Consumer Discretionary 15.26%
5 Consumer Staples 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLIR
51
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$1.12M 1.06%
26,571
+5,389
+25% +$224K
ABT icon
52
Abbott
ABT
$187B
$1.11M 1.05%
12,012
-1,189
-9% -$107K
ISRG icon
53
Intuitive Surgical
ISRG
$130B
$1.1M 1.04%
5,685
+2,412
+74% +$432K
AON icon
54
Aon
AON
$81.4B
$1.1M 1.04%
5,727
-255
-4% -$47.5K
ALXN
55
DELISTED
Alexion Pharmaceuticals
ALXN
$1.09M 1.04%
+9,714
New +$1.03M
BF.B icon
56
Brown-Forman Class B
BF.B
$13.3B
$1.08M 1.02%
16,749
-745
-4% -$47.5K
KEYS icon
57
Keysight
KEYS
$52.2B
$1.08M 1.02%
10,700
-475
-4% -$46.6K
ZM icon
58
Zoom
ZM
$26.8B
$1.06M 1.01%
+4,050
New +$729K
SBUX icon
59
Starbucks
SBUX
$118B
$1.05M 1%
14,263
-8,586
-38% -$645K
HPQ icon
60
HP
HPQ
$25.9B
$1.05M 0.99%
61,285
-2,735
-4% -$43.5K
REGN icon
61
Regeneron Pharmaceuticals
REGN
$72.9B
$1.04M 0.99%
+1,677
New +$952K
CLX icon
62
Clorox
CLX
$12.1B
$1.04M 0.99%
+4,673
New +$934K
EL icon
63
Estee Lauder
EL
$30.7B
$1.04M 0.98%
5,410
-240
-4% -$42.9K
LULU icon
64
lululemon athletica
LULU
$13.7B
$1.03M 0.98%
3,379
-3,832
-53% -$980K
MXIM
65
DELISTED
Maxim Integrated Products
MXIM
$1.02M 0.97%
16,951
-755
-4% -$42K
CL icon
66
Colgate-Palmolive
CL
$74.2B
$1.01M 0.96%
13,854
-615
-4% -$43.7K
VRTX icon
67
Vertex Pharmaceuticals
VRTX
$124B
$1.01M 0.96%
+3,489
New +$946K
LDOS icon
68
Leidos
LDOS
$14.9B
$1M 0.95%
10,683
-475
-4% -$46.8K
LMT icon
69
Lockheed Martin
LMT
$134B
$992K 0.94%
2,742
-120
-4% -$45.3K
ZBH icon
70
Zimmer Biomet
ZBH
$18.5B
$973K 0.92%
+8,315
New +$958K
QLYS icon
71
Qualys
QLYS
$4.78B
$966K 0.92%
9,229
-4,418
-32% -$463K
EW icon
72
Edwards Lifesciences
EW
$48.2B
$924K 0.88%
13,360
-593
-4% -$42.1K
TER icon
73
Teradyne
TER
$50.2B
$881K 0.84%
10,426
-6,681
-39% -$448K
PTON icon
74
Peloton Interactive
PTON
$2.84B
$871K 0.83%
+14,739
New +$610K
HSY icon
75
Hershey
HSY
$37.2B
$857K 0.81%
6,600
-290
-4% -$39K

Similar funds

Abacus FCF Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Abacus FCF Advisors held 93 positions worth $105M, up 20% from $87.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Abacus FCF Advisors withdrew a net $3.36M in Q2 2020, closing 12 positions and reducing 59 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $1.17M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Abacus FCF Advisors opened a new position in ExxonMobil worth $2.37M.

  • Abacus FCF Advisors's largest Q2 2020 buy was ExxonMobil: 53,803 shares worth $2.37M.
  • Abacus FCF Advisors added most to Morgan Stanley in Q2 2020, an estimated $552K increase.
  • Abacus FCF Advisors's biggest Q2 2020 reduction was lululemon athletica, cutting an estimated $980K.
  • Abacus FCF Advisors fully exited State Street Energy Select Sector SPDR ETF in Q2 2020, selling an estimated $1.17M.
  • Abacus FCF Advisors's ten largest holdings make up 22% of its $105M portfolio in Q2 2020.
  • Abacus FCF Advisors opened 16 new positions and closed 12 in Q2 2020.
  • Abacus FCF Advisors's portfolio value rose 20% quarter-over-quarter to $105M.

Based on Abacus FCF Advisors's 13F filing for Q2 2020, filed 10 Jul 2020.